Selection for RNA: peptide recognition through sulfur alkylation chemistry.
Wecker
M
M
NeXstar Pharmaceuticals, Boulder, Colorado 80301, USA.
Smith
D
D
D000478:Alkylation; D001920:Bradykinin / Q000031:analogs & derivatives* / Q000138:chemical synthesis; D002384:Catalysis; D004305:Dose-Response Relationship, Drug; D004591:Electrophoresis, Polyacrylamide Gel; D005821:Genetic Techniques; D006157:Guanosine Monophosphate / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000737:chemistry* / Q000302:isolation & purification* / Q000494:pharmacology; D007700:Kinetics; D010455:Peptides / Q000737:chemistry*; D010663:Phenylmercury Compounds / Q000138:chemical synthesis / Q000494:pharmacology; D012313:RNA / Q000737:chemistry* / Q000302:isolation & purification*; D012685:Sepharose / Q000737:chemistry; D013455:Sulfur / Q000378:metabolism*; D013873:Thionucleotides / Q000138:chemical synthesis / Q000494:pharmacology; D014158:Transcription, Genetic
C101934:N-bromoacetylbradykinin; D010455:Peptides; D010663:Phenylmercury Compounds; D013873:Thionucleotides; C101935:guanosine-5'-monophosphorothioate-RNA; D012313:RNA; D013455:Sulfur; C056922:((N-acryloylamino)phenyl)mercuric chloride; C066524:guanosine 5'-monophosphorothioate; D006157:Guanosine Monophosphate; D012685:Sepharose; D001920:Bradykinin